Bloomberg Novartis AG’s new gene therapy targeting a disease that kills infants would be cost-effective at as much as $1.5 million, according to a US nonprofit that assesses the value of drugs, well short of the potential price range the company has suggested. Zolgensma, a one-time treatment for a severe genetic disorder called spinal muscular atrophy, would provide substantial benefits ...

Bloomberg Volkswagen AG’s delicate balancing act between the old and new automotive eras will be on full display this week at the Geneva car show, where a fun-loving electric beach buggy will share the limelight with the trusty Passat sedan. VW’s I.D. Buggy concept combines battery power with styling reminiscent of carefree days tearing around California sand dunes, tapping a ...

Bloomberg Aston Martin fell the most since its controversial initial public offering (IPO) last year as the luxury carmaker said some UK and European buyers are delaying purchases amid uncertainty around Brexit. The stock dropped as much as 18 percent and was trading 17 percent lower at 1,138.6 pence in London. That’s less than two-thirds of the 19-pound price at ...